These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
359 related articles for article (PubMed ID: 29379164)
21. Type I IFN augments IL-27-dependent TRIM25 expression to inhibit HBV replication. Tan G; Xiao Q; Song H; Ma F; Xu F; Peng D; Li N; Wang X; Niu J; Gao P; Qin FX; Cheng G Cell Mol Immunol; 2018 Mar; 15(3):272-281. PubMed ID: 28194021 [TBL] [Abstract][Full Text] [Related]
22. An Integrated Systems Biology Approach Identifies TRIM25 as a Key Determinant of Breast Cancer Metastasis. Walsh LA; Alvarez MJ; Sabio EY; Reyngold M; Makarov V; Mukherjee S; Lee KW; Desrichard A; Turcan Ş; Dalin MG; Rajasekhar VK; Chen S; Vahdat LT; Califano A; Chan TA Cell Rep; 2017 Aug; 20(7):1623-1640. PubMed ID: 28813674 [TBL] [Abstract][Full Text] [Related]
23. Anti-cancer efficacy of SREBP inhibitor, alone or in combination with docetaxel, in prostate cancer harboring p53 mutations. Li X; Wu JB; Chung LW; Huang WC Oncotarget; 2015 Dec; 6(38):41018-32. PubMed ID: 26512780 [TBL] [Abstract][Full Text] [Related]
24. Expression of Tripartite Motif-Containing Proteactiin 11 (TRIM11) is Associated with the Progression of Human Prostate Cancer and is Downregulated by MicroRNA-5193. Pan Y; Zhang R; Chen H; Chen W; Wu K; Lv J Med Sci Monit; 2019 Jan; 25():98-106. PubMed ID: 30608062 [TBL] [Abstract][Full Text] [Related]
25. TRIM68 regulates ligand-dependent transcription of androgen receptor in prostate cancer cells. Miyajima N; Maruyama S; Bohgaki M; Kano S; Shigemura M; Shinohara N; Nonomura K; Hatakeyama S Cancer Res; 2008 May; 68(9):3486-94. PubMed ID: 18451177 [TBL] [Abstract][Full Text] [Related]
26. Identification and Validation of TRIM25 as a Glucose Metabolism Regulator in Prostate Cancer. Li C; Dou P; Lu X; Guan P; Lin Z; Zhou Y; Lu X; Lin X; Xu G Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012594 [TBL] [Abstract][Full Text] [Related]
27. The role of Trim25 in development, disease and RNA metabolism. Heikel G; Choudhury NR; Michlewski G Biochem Soc Trans; 2016 Aug; 44(4):1045-50. PubMed ID: 27528750 [TBL] [Abstract][Full Text] [Related]
28. TRIM25 is associated with cisplatin resistance in non-small-cell lung carcinoma A549 cell line via downregulation of 14-3-3σ. Qin X; Qiu F; Zou Z Biochem Biophys Res Commun; 2017 Nov; 493(1):568-572. PubMed ID: 28867193 [TBL] [Abstract][Full Text] [Related]
29. TRIM25 Enhances the Antiviral Action of Zinc-Finger Antiviral Protein (ZAP). Li MM; Lau Z; Cheung P; Aguilar EG; Schneider WM; Bozzacco L; Molina H; Buehler E; Takaoka A; Rice CM; Felsenfeld DP; MacDonald MR PLoS Pathog; 2017 Jan; 13(1):e1006145. PubMed ID: 28060952 [TBL] [Abstract][Full Text] [Related]
30. Resveratrol induces sumoylated COX-2-dependent anti-proliferation in human prostate cancer LNCaP cells. Cheng TM; Chin YT; Ho Y; Chen YR; Yang YN; Yang YC; Shih YJ; Lin TI; Lin HY; Davis PJ Food Chem Toxicol; 2018 Feb; 112():67-75. PubMed ID: 29242151 [TBL] [Abstract][Full Text] [Related]
31. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence. Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214 [TBL] [Abstract][Full Text] [Related]
32. Tripartite motif containing 25 promotes proliferation and invasion of colorectal cancer cells through TGF-β signaling. Sun N; Xue Y; Dai T; Li X; Zheng N Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28620119 [TBL] [Abstract][Full Text] [Related]
33. Positive regulatory role of c-Src-mediated TRIM25 tyrosine phosphorylation on RIG-I ubiquitination and RIG-I-mediated antiviral signaling pathway. Lee NR; Choi JY; Yoon IH; Lee JK; Inn KS Cell Immunol; 2018 Oct; 332():94-100. PubMed ID: 30100205 [TBL] [Abstract][Full Text] [Related]
34. TRIM47 silencing inhibits the malignant biological behaviors of prostate cancer cells by regulating MDM2/p53 signaling. Wang C; Chang R; Li J; Li L Cell Biochem Biophys; 2024 Jun; 82(2):1567-1578. PubMed ID: 38802602 [TBL] [Abstract][Full Text] [Related]
35. Topors acts as a SUMO-1 E3 ligase for p53 in vitro and in vivo. Weger S; Hammer E; Heilbronn R FEBS Lett; 2005 Sep; 579(22):5007-12. PubMed ID: 16122737 [TBL] [Abstract][Full Text] [Related]
36. 14-3-3 scaffold proteins mediate the inactivation of trim25 and inhibition of the type I interferon response by herpesvirus deconjugases. Gupta S; Ylä-Anttila P; Sandalova T; Sun R; Achour A; Masucci MG PLoS Pathog; 2019 Nov; 15(11):e1008146. PubMed ID: 31710640 [TBL] [Abstract][Full Text] [Related]
37. The deubiquitinase USP10 restores PTEN activity and inhibits non-small cell lung cancer cell proliferation. He Y; Jiang S; Mao C; Zheng H; Cao B; Zhang Z; Zhao J; Zeng Y; Mao X J Biol Chem; 2021 Sep; 297(3):101088. PubMed ID: 34416231 [TBL] [Abstract][Full Text] [Related]
38. Upregulated TRIM11 Exerts its Oncogenic Effects in Hepatocellular Carcinoma Through Inhibition of P53. Liu J; Rao J; Lou X; Zhai J; Ni Z; Wang X Cell Physiol Biochem; 2017; 44(1):255-266. PubMed ID: 29190611 [TBL] [Abstract][Full Text] [Related]
39. TRIM25 Is Required for the Antiviral Activity of Zinc Finger Antiviral Protein. Zheng X; Wang X; Tu F; Wang Q; Fan Z; Gao G J Virol; 2017 May; 91(9):. PubMed ID: 28202764 [TBL] [Abstract][Full Text] [Related]
40. TRIM25 blockade by RNA interference inhibited migration and invasion of gastric cancer cells through TGF-β signaling. Zhu Z; Wang Y; Zhang C; Yu S; Zhu Q; Hou K; Yan B Sci Rep; 2016 Jan; 6():19070. PubMed ID: 26754079 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]